NCT05438862 - Early Aortic vaLve surgEry Versus wAtchful waitiNg Strategy in Severe Asymptomatic aOrtic reguRgitation | Biotech Hunter

Enrollment

217

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Aortic Valve Regurgitation

Interventions

PROCEDURE

State of art aortic valve surgery

Optimal surgical treatment (aortic valve-sparing surgery, aortic valve replacement, Ross procedure).

Trial Locations (7)

9300

RECRUITING

Cardiovascular Center OLV Clinic Aalst, Aalst

11000

RECRUITING

University Clinical Center of Serbia, Belgrade

50005

RECRUITING

University Hospital Hradec Králové, Hradec Králové

65691

RECRUITING

Center of Cardiovascular and Transplant Surgery, Brno

656 91

ACTIVE_NOT_RECRUITING

International Clinical Research Center, St. Anne´s University Hospital Brno, Brno

128 08

RECRUITING

2nd Department of Internal Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague

150 30

RECRUITING

Na Homolce Hospital, Prague

All Listed Sponsors

collaborator

University Hospital Hradec Kralove

OTHER

collaborator

Centre of Cardiovascular and Transplantation Surgery, Czech Republic

OTHER

collaborator

St. Anne's University Hospital Brno, Czech Republic

OTHER

collaborator

VZW Cardiovascular Research Center Aalst

OTHER

collaborator

General University Hospital, Prague

OTHER

collaborator

University Clinical Centre of Republic of Srpska

OTHER

lead

Na Homolce Hospital

OTHER